Cognyte Software Valuation
Is CGNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CGNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CGNT ($7.82) is trading below our estimate of fair value ($13.39)
Significantly Below Fair Value: CGNT is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CGNT?
Key metric: As CGNT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is CGNT's PS Ratio? | |
|---|---|
| PS Ratio | 1.7x |
| Sales | US$330.21m |
| Market Cap | US$562.22m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.6x |
| Enterprise Value/EBITDA | 542.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CGNT's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8.8x | ||
EXOD Exodus Movement | 6.8x | n/a | US$608.6m |
HKD AMTD Digital | 20.6x | n/a | US$572.6m |
BTBT Bit Digital | 6.7x | 43.4% | US$655.6m |
MGIC Magic Software Enterprises | 1x | 3.9% | US$539.6m |
CGNT Cognyte Software | 1.7x | 7.6% | US$562.2m |
Price-To-Sales vs Peers: CGNT is good value based on its Price-To-Sales Ratio (1.7x) compared to the peer average (8.8x).
Price to Sales Ratio vs Industry
How does CGNT's PS Ratio compare vs other companies in the US Software Industry?
Price-To-Sales vs Industry: CGNT is good value based on its Price-To-Sales Ratio (1.7x) compared to the US Software industry average (5.3x).
Price to Sales Ratio vs Fair Ratio
What is CGNT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.7x |
| Fair PS Ratio | 2.3x |
Price-To-Sales vs Fair Ratio: CGNT is good value based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$7.82 | US$8.25 +5.5% | 9.1% | US$9.00 | US$7.50 | n/a | 2 |
| Nov ’25 | US$6.45 | US$8.25 +27.9% | 9.1% | US$9.00 | US$7.50 | n/a | 2 |
| Oct ’25 | US$6.55 | US$9.17 +39.9% | 15.6% | US$11.00 | US$7.50 | n/a | 3 |
| Sep ’25 | US$7.66 | US$9.17 +19.7% | 15.6% | US$11.00 | US$7.50 | n/a | 3 |
| Aug ’25 | US$7.40 | US$9.17 +23.9% | 15.6% | US$11.00 | US$7.50 | n/a | 3 |
| Jul ’25 | US$7.68 | US$9.17 +19.4% | 15.6% | US$11.00 | US$7.50 | n/a | 3 |
| Jun ’25 | US$7.60 | US$8.83 +16.2% | 17.5% | US$11.00 | US$7.50 | n/a | 3 |
| May ’25 | US$6.83 | US$8.83 +29.3% | 17.5% | US$11.00 | US$7.50 | n/a | 3 |
| Apr ’25 | US$8.26 | US$6.67 -19.2% | 35.4% | US$10.00 | US$5.00 | n/a | 3 |
| Mar ’25 | US$7.57 | US$6.67 -11.9% | 35.4% | US$10.00 | US$5.00 | n/a | 3 |
| Feb ’25 | US$7.13 | US$6.67 -6.5% | 35.4% | US$10.00 | US$5.00 | n/a | 3 |
| Jan ’25 | US$6.43 | US$6.67 +3.7% | 35.4% | US$10.00 | US$5.00 | n/a | 3 |
| Dec ’24 | US$5.27 | US$6.50 +23.3% | 32.6% | US$9.50 | US$5.00 | n/a | 3 |
| Nov ’24 | US$4.10 | US$6.50 +58.5% | 32.6% | US$9.50 | US$5.00 | US$6.45 | 3 |
| Oct ’24 | US$4.81 | US$7.25 +50.7% | 31.0% | US$9.50 | US$5.00 | US$6.55 | 2 |
| Sep ’24 | US$4.78 | US$6.50 +36.0% | 32.6% | US$9.50 | US$5.00 | US$7.66 | 3 |
| Aug ’24 | US$5.76 | US$6.50 +12.8% | 32.6% | US$9.50 | US$5.00 | US$7.40 | 3 |
| Jul ’24 | US$6.09 | US$5.33 -12.4% | 8.8% | US$6.00 | US$5.00 | US$7.68 | 3 |
| Jun ’24 | US$5.14 | US$4.67 -9.2% | 26.7% | US$6.00 | US$3.00 | US$7.60 | 3 |
| May ’24 | US$4.20 | US$4.67 +11.1% | 26.7% | US$6.00 | US$3.00 | US$6.83 | 3 |
| Apr ’24 | US$3.39 | US$6.00 +77.0% | 49.1% | US$10.00 | US$3.00 | US$8.26 | 3 |
| Mar ’24 | US$3.66 | US$5.25 +43.4% | 54.5% | US$10.00 | US$3.00 | US$7.57 | 4 |
| Feb ’24 | US$3.89 | US$5.25 +35.0% | 54.5% | US$10.00 | US$3.00 | US$7.13 | 4 |
| Jan ’24 | US$3.11 | US$5.25 +68.8% | 54.5% | US$10.00 | US$3.00 | US$6.43 | 4 |
| Dec ’23 | US$3.12 | US$6.50 +108.3% | 31.7% | US$10.00 | US$5.00 | US$5.27 | 4 |
| Nov ’23 | US$2.73 | US$6.50 +138.1% | 31.7% | US$10.00 | US$5.00 | US$4.10 | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Dye & Durham
CA$1.2b
Provides cloud-based software and technology solutions for law firms, financial service institutions, sole-practitioner law firms, and government organizations in Canada, Australia, South Africa, Ireland, and the United Kingdom.
DYND.F
CA$12.80
7D
6.1%
1Y
33.2%
Information Services Group
US$163.7m
Operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific.
III
US$3.53
7D
5.4%
1Y
-19.2%
Enghouse Systems
CA$1.6b
Develops enterprise software solutions worldwide.
EGHS.F
CA$20.88
7D
-5.3%
1Y
-17.0%